BBIO earnings date and last-quarter result: last quarter miss, P/E -22.04. Updated 2026-07-23.
BridgeBio Pharma (BBIO) Research Hub
BridgeBio Pharma (BBIO) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 68.15 USD (-0.60%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -22.04, market cap 16.09B. This hub links to the full technical, earnings and options research available for BBIO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 68.15 USD (-0.60%) |
| 52-week range | 62.95 USD – 93.42 USD |
| Trend regime | Range |
| 14-day RSI | 54.6 (Neutral) |
| Trailing P/E | -22.04 |
| Market cap | 16.09B |
| Dividend yield | 0.00% |
Available research for BBIO
Covered Call on BBIO: how it works, illustrative setup around the real 68.15 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BBIO: how it works, illustrative setup around the real 68.15 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BBIO: how it works, illustrative setup around the real 68.15 USD price, max profit/loss, breakeven and when to use it. Educational.
BBIO technical analysis: range, last 68.15 USD, RSI 54.6, 52w range 62.95 USD–93.42 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BBIO in?
BridgeBio Pharma (BBIO) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BBIO in an uptrend or downtrend?
As of 2026-10-26, BBIO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BBIO's trailing P/E ratio?
BBIO's trailing P/E is -22.04, with a market cap of 16.09B. See the earnings research page for full valuation detail.